Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1988-09-16
1990-10-30
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
260404, 514512, 514529, 514530, 514544, 514532, 514546, 514549, 514552, 558271, 560 1, 560 55, 560 65, 560 73, 560105, 560109, 560122, 560123, 560124, 560125, 560126, 560142, C07C 6900, A61K 31215
Patent
active
049669150
ABSTRACT:
An L-dopa derivative represented by formula (I) ##STR1## wherein one of R.sup.1 and R.sup.2 denotes a hydrogen atom and the other denotes a group of formula R--CO-- in which R denotes an alkyl, alkenyl, optionally substituted cycloalkyl, optionally substituted phenyl, optionally substituted aralkyl, lower alkoxy or optionally substituted aralkyloxy group,
and its acid addition salt. The compounds are useful in the medical field, especially in the treatment of a series of diseases called Parkinson's disease or Parkinsonism.
REFERENCES:
patent: 2868818 (1959-01-01), Pfister
patent: 3725470 (1973-04-01), Bretschneider
patent: 3859331 (1975-01-01), Kaiser
patent: 3891696 (1975-06-01), Bodor
patent: 3983138 (1976-09-01), Saari
patent: 4311706 (1982-01-01), Bodor
Roche, "Design of Biopharmaceutical Properties through Prodrugs and Analogs".
Hayashi Masahiro
Hisaka Akihiro
Ihara Masaki
Sawasaki Yoshio
Takehana Hiroshi
Banyu Pharmaceutical Co. Ltd.
Shippen Michael L.
LandOfFree
L-dopa derivatives or their acid addition salts, process for pro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with L-dopa derivatives or their acid addition salts, process for pro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and L-dopa derivatives or their acid addition salts, process for pro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-275519